Mary Beth Chalk
About Mary Beth
Mary Beth Chalk has over 25 years of experience in creating, validating, and commercializing digital health solutions. This included her role as a co-founder of an AI platform leveraging device data and social determinants to provide personalized disease management.
In December 2019, Mary Beth was diagnosed with Stage 1 invasive ductal carcinoma after a routine mammogram. Following her lumpectomy in January she underwent 5-days of internal radiation. From screening to the completion of radiation, her cancer journey was 60-days. As her surgeon said, “We have got to get the news out about early stage breast cancer!”